Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy have?
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy has 136 citations in the OpenAlex counts ScholarIQ stores.
When was Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy published?
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy has 2024 year in the ScholarIQ index.
What is the open-access status of Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy?
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy?
The DOI for Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy is on the source record.
What is the PMID of Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy?
The PMID for Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy is on the source record.
What is the OpenAlex record for Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy?
The OpenAlex for Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy is on the source record.